Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.041
Neutral
RSI(14)
27.354
Sell
STOCH(KDJ)(9,3,3)
38.760
Neutral
ATR(14)
0.017
Low Volatility
CCI(14)
-75.852
Neutral
Williams %R
74.872
Sell
TRIX(12,20)
-3.729
Sell
StochRSI(14)
68.267
Neutral
Search
Biomx Inc
PHGEAdd to Watchlist
0.186USD
-0.003-1.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.22MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.48%
5 Days
-1.59%
1 Month
-41.75%
6 Months
-96.75%
Year to Date
-90.05%
1 Year
-97.49%
Key Figures
0.186Open
0.194High
900.94KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
13.77%Turnover Ratio
0.189Prev. Close
0.183Low
77.53KTurnover
LossP/E Static
-0.06P/B
0.00%Div Yield TTM
-147.70%ROA
14.71252wk High
0.28Volume Ratio
-17.73MNet Profit
6.54MShares
-22.1939EPS TTM
1.25Beta
-672.21%ROE
0.36152wk Low
5.93%Amplitude
--Gross Margin
1.22MMarket Cap
-4.56Reward/Risk
8.95%Risk Rate
Biomx Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Hold
Current Rating
26.000
Target Price
+610.38%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Biomx Inc
PHGE
1
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.187
Sell
MA10
0.194
Sell
MA20
0.219
Sell
MA50
0.517
Sell
MA100
1.601
Sell
MA200
3.496
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Biomx Inc Info
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Ticker SymbolPHGE
CompanyBiomx Inc
CEOSolomon (Jonathan Eitan)
Websitehttps://www.biomx.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Biomx Inc (PHGE)?
The current price of Biomx Inc (PHGE) is 0.19.
What is the symbol of Biomx Inc?
The ticker symbol of Biomx Inc is PHGE.
What is the 52-week high of Biomx Inc?
The 52-week high of Biomx Inc is 14.71.
What is the 52-week low of Biomx Inc?
The 52-week low of Biomx Inc is 0.36.
What is the market capitalization of Biomx Inc?
The market capitalization of Biomx Inc is 1.22M.
Is Biomx Inc (PHGE) currently rated as Buy, Hold, or Sell?
According to analysts, Biomx Inc (PHGE) has an overall rating of signal_hold, with a price target of 26.00.
What is the Earnings Per Share (EPS TTM) of Biomx Inc (PHGE)?
The Earnings Per Share (EPS TTM) of Biomx Inc (PHGE) is -22.19.